Company intelligence / Profile preview

Wuhan Zijing Pharmaceutical

Ownership: Private
Development stage: Other

Overview

Wuhan Zijing Pharmaceutical is a China-based pharmaceutical enterprise focused on the research, production, and sale of chemical drugs and traditional Chinese medicine preparations. Headquartered in the Jiangxia District of Wuhan, the company operates modern manufacturing facilities that adhere to national GMP standards. Its core product offerings include treatments for chronic hepatitis, skin diseases, and various viral infections, with a significant market presence in glycyrrhizin-derived products. The company serves as a regional hub for pharmaceutical manufacturing, providing both active pharmaceutical ingredients and finished dosage forms to the Chinese healthcare market.

Therapeutic areas: Infectious DiseasesDermatology
Modalities: Small moleculeBotanical extract
Industry: Pharma

Drug pipeline

1 asset

citicoline sodium

Beyond the preview

Go deeper on Wuhan Zijing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wuhan Zijing Pharmaceutical.